Which funds own XENE
Xenon Pharmaceuticals Inc in the Q2 2026 filings. At least 1 of the 91 current managers on file reported a position, worth $253m between them. It is among the largest positions of fewer than a fifth of the current managers on file. Buying and selling roughly cancelled this quarter, which is what a name looks like when the argument is still live.
- Managers holding
- 1
- at least, of 91 current
- Combined value
- $253m
- as reported
- Opened
- 0
- new this quarter
- Added to
- 1
- already held
- Trimmed or sold out
- 1
- 1 sold out entirely
Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.
Managers reporting a position
Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.
| Manager | Value | Weight | Shares | Change on the quarter | Action |
|---|---|---|---|---|---|
| Janus Henderson Group Ltd Long-only · $245bn book | $253m | 0.1% | 4,186,519 | +$9.8m+10,537 | Added |
Sold out of this quarter
Valued at what the position was worth in the previous filing, because by this one it is gone.
- Holocene Advisors LP · Long/short equity$88m held before
Ownership through time
At least 9 of the 95 managers whose filings are on file listed XENE in Q2 2026, against 1 in Q4 2014. 1 manager more than in Q1 2026: 1 started a position; 2 listed it again; 2 no longer listed it among the positions read, which can mean a holding below the listed range, a filing that reported no holdings, or a filing not yet made.
Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.
- Q4 2014: 1
- Q1 2015: 1
- Q3 2015: 1
- Q4 2015: 1
- Q1 2016: 1
- Q2 2016: 1
- Q3 2016: 1
- Q4 2016: 1
- Q1 2017: 1
- Q2 2017: 2
- Q3 2017: 2
- Q4 2017: 2
- Q1 2018: 2
- Q2 2018: 3
- Q3 2018: 5
- Q4 2018: 3
- Q1 2019: 4
- Q2 2019: 3
- Q3 2019: 3
- Q4 2019: 3
- Q1 2020: 2
- Q2 2020: 3
- Q1 2021: 1
- Q2 2021: 1
- Q3 2021: 2
- Q4 2021: 4
- Q1 2022: 6
- Q2 2022: 7
- Q3 2022: 7
- Q4 2022: 8
- Q1 2023: 9
- Q2 2023: 5
- Q3 2023: 7
- Q4 2023: 11
- Q1 2024: 6
- Q2 2024: 7
- Q3 2024: 7
- Q4 2024: 6
- Q1 2025: 5
- Q2 2025: 5
- Q3 2025: 5
- Q4 2025: 6
- Q1 2026: 8
- Q2 2026: 9
- Q4 2014: $12m
- Q1 2015: $11m
- Q3 2015: $8.5m
- Q4 2015: $8.3m
- Q1 2016: $7.2m
- Q2 2016: $6.1m
- Q3 2016: $8.3m
- Q4 2016: $9.4m
- Q1 2017: $5.7m
- Q2 2017: $4.9m
- Q3 2017: $5.0m
- Q4 2017: $5.1m
- Q1 2018: $8.9m
- Q2 2018: $17m
- Q3 2018: $21m
- Q4 2018: $9.5m
- Q1 2019: $24m
- Q2 2019: $19m
- Q3 2019: $17m
- Q4 2019: $25m
- Q1 2020: $18m
- Q2 2020: $21m
- Q1 2021: $14m
- Q2 2021: $17m
- Q3 2021: $20m
- Q4 2021: $205m
- Q1 2022: $215m
- Q2 2022: $230m
- Q3 2022: $330m
- Q4 2022: $303m
- Q1 2023: $259m
- Q2 2023: $222m
- Q3 2023: $220m
- Q4 2023: $590m
- Q1 2024: $396m
- Q2 2024: $383m
- Q3 2024: $428m
- Q4 2024: $400m
- Q1 2025: $343m
- Q2 2025: $224m
- Q3 2025: $415m
- Q4 2025: $501m
- Q1 2026: $1.3bn
- Q2 2026: $1.2bn
Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.
Started in Q2 2026
Largest increases, by shares
- Marshall Wace LLPnew: 689,342 shares+$42m
- Tudor Investment Corp495,591 to 545,387 shares+$3.0m
- Capital World Investors840,072 to 862,775 shares+$1.4m
- Janus Henderson Group Ltd4,175,982 to 4,186,519 shares+$636k
Largest decreases, by shares
- Fidelity (FMR LLC)10,818,491 to 9,647,998 shares-$71m
- Schonfeld Strategic Advisors LLC324,722 to 227,330 shares-$5.9m
- ExodusPoint Capital Management LP173,425 to 84,591 shares-$5.4m
Left it
No manager on file is shown leaving it.
| Manager | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Fidelity (FMR LLC) | Q1 2026 | $629m | $582m | |
| Janus Henderson Group Ltd | Q4 2023 | $253m | $253m | |
| Two Sigma Investments LP | Q4 2023 | $99m | $99m | |
| AllianceBernstein LP | Q4 2023 | $91m | $91m | |
| Capital World Investors | Q4 2014 | $124m | $52m | |
| Marshall Wace LLP | Q4 2021 | $101m | $42m | |
| Tudor Investment Corp | Q1 2026 | $33m | $33m | |
| Schonfeld Strategic Advisors LLC | Q2 2017 | $19m | $14m | |
| ExodusPoint Capital Management LP | Q1 2023 | $14m | $5.1m | |
| Wellington Management Group LLP | Q4 2023 | $281m | last listed Q1 2026 | |
| Point72 Asset Management LP | Q1 2019 | $93m | last listed Q2 2024 | |
| Holocene Advisors LP | Q1 2022 | $88m | last listed Q1 2026 | |
| Woodline Partners LP | Q3 2021 | $15m | last listed Q4 2023 | |
| Two Sigma Advisers LP | Q4 2023 | $12m | last listed Q4 2025 | |
| Moore Capital Management LP | Q3 2018 | $6.3m | last listed Q4 2025 | |
| Walleye Capital LLC | Q3 2018 | $4.9m | last listed Q1 2023 | |
| PDT Partners LLC | Q2 2018 | $372k | last listed Q2 2020 |
What XENE is worth
Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.
Build the comp set around XENE →How much of the picture this is
A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.
What to do with a name the funds are buying
Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More
The holdings, every quarter, and the week between
One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.
One email a week, free, and you can leave at any point.